首页> 外文期刊>Ophthalmology and therapy. >Historical Review and Update of Surgical Treatment for Corneal Endothelial Diseases
【24h】

Historical Review and Update of Surgical Treatment for Corneal Endothelial Diseases

机译:角膜内皮病外科治疗的历史回顾与更新

获取原文

摘要

The cornea remains in a state of deturgescence, maintained by endothelial cell Na+/K+ ATPase and by tight junctions between endothelial cells that limit entrance of fluid into the stroma. Fuchs’ endothelial corneal dystrophy (FECD) was initially described by Fuchs in 1910 as a combination of epithelial and stromal edema in older patients. It manifests as bilateral, albeit asymmetric, central corneal guttae, corneal edema, and reduced vision. When edema is severe, the corneal epithelium can detach from its basement membrane, creating painful bullae on the anterior surface of the cornea. The course of this dystrophy can be further accelerated after intraocular surgery, specifically cataract extraction. Pseudophakic bullous keratopathy (PBK) is endothelial cell loss caused by surgery in the anterior chamber. If the corneal endothelium is damaged during surgery, the same spectrum of symptoms as found in FECD can develop. In the nineteenth century, penetrating keratoplasty was the only surgical procedure available for isolated endothelial disease. In the 1960s, Dr. José Barraquer described a method of endothelial keratoplasty using an anterior approach via laser-assisted in situ keratomileusis (LASIK) flap. In 1999, Melles and colleague described their technique of posterior lamellar keratoplasty. Later, Melles et al. started to change host dissection using simple “descemetorhexis” in a procedure known as Descemet’s stripping endothelial keratoplasty. Following the widespread adoption of Descemet’s stripping automated endothelial keratoplasty, the Melles group revisited selective Descemet’s membrane transplantation and reported the results of a new procedure, Descemet’s membrane endothelial keratoplasty (DMEK). Recently, some eye banks have experimented with the preparation of DMEK/Descemet’s membrane automated endothelial keratoplasty donor tissue that may help the surgeon avoid the risk of tissue loss during the stromal separation step. Recently, the authors described a new bimanual technique for insertion and positioning of endothelium–Descemet membrane grafts in DMEK.
机译:角膜保持在去角质状态,通过内皮细胞Na + / K + ATPase以及内皮细胞之间的紧密连接来维持,从而限制液体进入基质。 Fuchs最初在1910年将Fuchs的内皮角膜营养不良(FECD)描述为老年患者的上皮和基质水肿的组合。它表现为双侧(尽管不对称)中央角膜牙龈,角膜浮肿和视力下降。当水肿严重时,角膜上皮会从其基底膜脱落,从而在角膜的前表面形成疼痛的大疱。眼内手术后,特别是白内障摘除术后,该营养不良的病程可以进一步加速。假晶状体大疱性角膜病变(PBK)是前房手术引起的内皮细胞丢失。如果在手术过程中角膜内皮受损,则会出现与FECD中相同的症状。在19世纪,穿透性角膜移植术是唯一可用于孤立的内皮病的外科手术方法。 1960年代,JoséBarraquer博士描述了一种通过激光辅助原位角膜磨镶术(LASIK)皮瓣使用前路方法进行内皮角膜移植术的方法。在1999年,Melles和同事描述了他们的后板层角膜移植技术。后来,梅尔斯等。开始采用称为“ Descemet的剥离内皮角膜移植术”的方法,通过简单的“去头皮囊切除术”改变宿主解剖。在Descemet的剥离自动内皮角膜移植术被广泛采用之后,Melles组重新考虑了选择性Descemet的膜移植,并报告了一种新方法的结果,即Descemet的膜内皮角膜移植术(DMEK)。最近,一些眼库已经尝试了DMEK / Descemet的膜自动内皮角膜移植供体组织的制备,这可能有助于外科医生避免在基质分离步骤中损失组织的风险。最近,作者描述了一种新的双向技术,用于在DMEK中插入和定位内皮-Descemet膜移植物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号